Table 4.
Laboratory findings on admission.
| Variable, Median (IQR) | N with Data | Total | Deaths | Live Discharges | p-Value |
|---|---|---|---|---|---|
| Entire cohort | n = 2226 | n = 460 | n = 1766 | ||
| Lymphocyte count, | 1805 | 0.93 (0.91–0.97) | 0.68 (0.64–0.74) | 1.02 (0.99–1.06) | < 0.001 (w) |
| ×10⁹/L | |||||
| (NR, 1.1–4.5) | |||||
| ALT, U/L | 1526 | 31 (30–33) | 28 (27–31) | 32 (31–34) | < 0.001 (w) |
| (NR, 0–35) | |||||
| Albumin g/dL | 1200 | 4.2 (4.2–4.3) | 3.9 (3.9–4) | 4.3 (4.3–4.4) | < 0.001 (w) |
| (NR, 2.9–5.2) | |||||
| Creatine kinase, U/L | 1241 | 100 (95–105) | 143 (121–164) | 88 (83–95) | < 0.001 (w) |
| (NR, 40–280) | |||||
| Creatinine mg/dL | 1602 | 0.81 (0.8–0.83) | 1.05 (0.99–1.13) | 0.77 (0.75–0.78) | < 0.001 (w) |
| (NR, 0.7–1.3) | |||||
| D-dimer, ng/mL | 982 | 720 (680–758) | 1590 (1309–1952) | 608 (560–648) | < 0.001 (w) |
| (NR, 0–500) | |||||
| Serum ferritin, ng/L | 599 | 346 (312–393) | 588 (490–741) | 313 (261–358) | < 0.001 (w) |
| (NR, 22–322) | |||||
| Platelet count, ×10⁹/L | 1605 | 218 (213–225) | 198 (186–206) | 226 (219–234) | < 0.001 (w) |
| (NR, 150–370) | |||||
| IL-6, pg/mL | 90 | 28.4 (18.8–40.1) | 30.9 (27.2–244) | 26 (17.9–43.9) | < 0.251 (w) |
| (NR, 0–3.4) | |||||
| Lactate dehydrogenase, U/L (NR, 100–190) | 1458 | 321 (315–330) | 380 (364–408) | 308 (301–316) | < 0.001 (w) |
| Procalcitonin, ng/mL | 637 | 0.12 (0.1–0.14) | 0.4 (0.3–0.5) | 0.09 (0.08–0.11) | < 0.001 (w) |
| (NR, 0–0.5) | |||||
| C-reactive protein, mg/L | 1482 | 71.1 (65.6–77.4) | 137.7 (118.1–153.8) | 57.8 (51.8–62) | < 0.001 (w) |
| (NR, 0–5) | |||||
| Prothrombin time, s | 1581 | 11.1 (11.1–11.2) | 11.5 (11.4–11.7) | 10.9 (10.9–11) | < 0.001 (w) |
| High-sensitivity cardiac | 253 | 11.2 (9.1–18.2) | 66.9 (29.7–115.2) | 8.2 (6.4–11) | < 0.001 (w) |
| troponin I, ng/L | |||||
| (NR, 0–53.5) | |||||
| ICU cohort | n=75 | n=55 | n=20 | ||
| Lymphocyte count, × 10⁹/L | 72 | 0.85 (0.77–0.97) | 0.77 (0.66–0.85) | 0.98 (0.87–1.15) | 0.009 (w) |
| (NR, 1.1–4.5) | |||||
| ALT, U/L | 53 | 38 (32–51) | 35 (31–52) | 47 (29–73) | 0.358 (w) |
| (NR, 0–35) | |||||
| Albumin, g/dL | 28 | 4.1 (4.0–4.3) | 4.1 (4–4.4) | 4.3 (4–4.4) | 0.494 (w) |
| (NR, 2.9–5.2) | |||||
| Creatine kinase, U/L | 33 | 122 (102–176 | 122 (99–176) | 135 (107–329) | 0.679 (w) |
| (NR, 40–280) | |||||
| Creatinine, mg/dL | 64 | 0.89 (0.8–1) | 0.92 (0.82–1.16) | 0.85 (0.73–0.97) | 0.094 (w) |
| (NR, 0.7–1.3) | |||||
| D-dimer, ng/mL | 26 | 1075 (752–1256) | 1088 (745–1824) | 758 (752–1647) | 0.527 (w) |
| (NR, 0–500) | |||||
| Serum ferritin, ng/L | 3 | 817 (520–852) | 835 (817–852) | 520 | 1.000 (w) |
| (NR, 22–322) | |||||
| Platelet count, ×10⁹/L | 65 | 185 (170–224) | 185 (165–225) | 205 (175–265) | 0.654 (w) |
| (NR, 150–370) | |||||
| IL-6, pg/mL | 3 | 30.9 (11.5–244.0) | 30.9 (11.5–244) | - | - |
| (NR, 0–3.4) | |||||
| Lactate dehydrogenase, U/L (NR, 100–190) | 33 | 365 (323–451) | 388 (332–520) | 328 (240–401) | 0.190 (w) |
| Procalcitonin, ng/mL | 17 | 0.2 (0.1–0.5) | 0.38 (0.12–0.93) | 0.08 (0.06–0.16) | 0.019 (w) |
| (NR, 0–0.5) | |||||
| C-reactive protein, mg/L | 58 | 139.8 (109.8–188.4) | 151 (118.1–203) | 123.8 (25.1–169.7) | 0.048 (w) |
| (NR, 0–5) | |||||
| Prothrombin time, s | 63 | 11.2 (11.0–11.4) | 11.3 (11–11.5) | 11.1 (10.5–11.4) | 0.177 (w) |
| High-sensitivity cardiac | 7 | 24.6 (11.2–92.7) | 15.4 (11.2–73.4) | 80.2 (67.2–92.7) | 0.190 (w) |
| troponin I, ng/L | |||||
| (NR, 0–53.5) |
Abbreviations: ALT, alanine aminotransferase; ICU, intensive care unit; IL, interleukin; IQR, interquartile range; NR, normal range.